Immunoglobulin treatment for B-cell immunodeficiencies

Abstract

This article aims to describe the rationale and utility of immunoglobulin therapies in patients with B-cell immunodeficiency states. We describe the historical perspective, mechanism of actions, and indications for use in this population. We then focus upon management pearls and special considerations for its utility. Finally, we elaborate upon the important economic implications for these patients and the need to develop individualized management strategies in this vulnerable population.

Keywords: IVIG; Immunodeficiency; Immunoglobulin; Vaccine.